p53 controls hepatitis C virus non-structural protein 5A-mediated downregulation of GADD45α expression via the NF-κB and PI3K–Akt pathways

por Cheng, Du, Zhao, Lei, Zhang, Leiliang, Jiang, Yongfang, Tian, Yi, Xiao, Xinqiang, Gong, Guozhong
Publicado 2013

HBx promotes cell proliferation by disturbing the cross-talk between miR-181a and PTEN

por Tian, Yi, Xiao, Xinqiang, Gong, Xing, Peng, Feng, Xu, Yun, Jiang, Yongfang, Gong, Guozhong
Publicado 2017

miR-3 Encoded by Hepatitis B Virus Downregulates PTEN Protein Expression and Promotes Cell Proliferation

por Tang, Jian, Xiao, Xinqiang, Jiang, Yongfang, Tian, Yi, Peng, Zhongtian, Yang, Meichan, Xu, Zhenyu, Gong, Guozhong
Publicado 2020

HBx Down-Regulated Gld2 Plays a Critical Role in HBV-Related Dysregulation of miR-122

por Peng, Feng, Xiao, Xinqiang, Jiang, Yongfang, Luo, Kaizhong, Tian, Yi, Peng, Milin, Zhang, Min, Xu, Yun, Gong, Guozhong
Publicado 2014

HIV Vpr protein upregulates microRNA-122 expression and stimulates hepatitis C virus replication

por Peng, Milin, Xiao, Xinqiang, He, Yan, Jiang, Yongfang, Zhang, Min, Peng, Feng, Tian, Yi, Xu, Yun, Gong, Guozhong
Publicado 2015

Hepatitis B virus X protein-induced upregulation of CAT-1 stimulates proliferation and inhibits apoptosis in hepatocellular carcinoma cells

por Dai, Rongjuan, Peng, Feng, Xiao, Xinqiang, Gong, Xing, Jiang, Yongfang, Zhang, Min, Tian, Yi, Xu, Yun, Ma, Jing, Li, Mingming, Luo, Yue, Gong, Guozhong
Publicado 2017

Clinical characteristics of older and younger patients infected with SARS-CoV-2

por Zhou, Zhiguo, Zhang, Min, Wang, Yali, Zheng, Fang, Huang, Yaxiong, Huang, Kang, Yu, Qizhi, Cai, Chunlin, Chen, Dong, Tian, Yi, Lei, Jianhua, Xiao, Xinqiang, Clercq, Erik De, Li, Guangdi, Xie, Yuanlin, Gong, Guozhong
Publicado 2020

Rapidly decreased HBV RNA predicts responses of pegylated interferons in HBeAg-positive patients: a longitudinal cohort study

por Zhang, Min, Li, Guangdi, Shang, Jia, Pan, Chen, Zhang, Minxiang, Yin, Zhibiao, Xie, Qing, Peng, Yanzhong, Mao, Qing, Xiao, Xinqiang, Jiang, Yongfang, Luo, Kaizhong, Xu, Yun, Ding, Hai, Fan, Wenzhou, Diego, Vidaurre, Pourkarim, Mahmoud Reza, De Clercq, Erik, Wang, Guiqiang, Gong, Guozhong
Publicado 2020

SARS-CoV-2 clearance in COVID-19 patients with Novaferon treatment: A randomized, open-label, parallel-group trial

por Zheng, Fang, Zhou, Yanwen, Zhou, Zhiguo, Ye, Fei, Huang, Baoying, Huang, Yaxiong, Ma, Jing, Zuo, Qi, Tan, Xin, Xie, Jun, Niu, Peihua, Wang, Wenlong, Xu, Yun, Peng, Feng, Zhou, Ning, Cai, Chunlin, Tang, Wei, Xiao, Xinqiang, Li, Yi, Zhou, Zhiguang, Jiang, Yongfang, Xie, Yuanlin, Tan, Wenjie, Gong, Guozhong
Publicado 2020

Reply to “Novaferon, treatment in COVID-19 patients”

por Zheng, Fang, Zhou, Yanwen, Zhou, Zhiguo, Ye, Fei, Huang, Baoying, Huang, Yaxiong, Ma, Jing, Zuo, Qi, Tan, Xin, Xie, Jun, Niu, Peihua, Wang, Wenlong, Xu, Yun, Peng, Feng, Zhou, Ning, Cai, Chunlin, Tang, Wei, Xiao, Xinqiang, Li, Yi, Zhou, Zhiguang, Jiang, Yongfang, Xie, Yuanlin, Tan, Wenjie, Gong, Guozhong
Publicado 2021